作者:TOJA, E.、OMODEI-SALE, A.、FAVARA, D.、CATTANEO, C.、GALLICO, L.、GALLIANI, G.
DOI:——
日期:——
BABICHEV, F. S.;DEMCHENKO, A. M.;KOVTUNENKO, V. A.;TYLTIN, A. K., YKP. XIM. ZH., 1984, 50, N 6, 623-626
作者:BABICHEV, F. S.、DEMCHENKO, A. M.、KOVTUNENKO, V. A.、TYLTIN, A. K.
DOI:——
日期:——
KOVTUNENKO V. A.; DEMCHENKO A. M.; TYLTIN A. K.; BABICHEV F. S.; VOJTENKO+, YKP. XIM. ZH., 53,(1987) N 2, 192-194
作者:KOVTUNENKO V. A.、 DEMCHENKO A. M.、 TYLTIN A. K.、 BABICHEV F. S.、 VOJTENKO+
DOI:——
日期:——
MAP4K4 INHIBITORS
申请人:IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
公开号:US20200339583A1
公开(公告)日:2020-10-29
This invention relates to pyrrolopyrimidine comprising compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these pyrrolopyrimidine comprising compounds, for example in a method of treatment. There are also provided processes for producing compounds of the present invention and method of their use. In particular, the present invention relates to compounds of formula (I).